Burkhardt, Ute E. http://orcid.org/0000-0003-1244-6643
Fritsch, Edward F. http://orcid.org/0000-0002-8412-5665
Funding for this research was provided by:
ACIR is a not-for-profit organization supported by generous philanthropic donations from individuals and industry.
Article History
Received: 4 October 2023
Revised: 19 October 2023
Accepted: 24 October 2023
First Online: 11 December 2023
Competing interests
: EFF is an equity holder and consultant for BioNTech, and equity holder and SAB member of BioEntre, and equity holder in Dionis Therapeutics. UEB is an equity holder in BioEntre, BioNTech and Dionis Therapeutics.